News Image

BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program

Provided By GlobeNewswire

Last update: Jun 13, 2024

- Brown adipose derived stem cells with brown adipogenic potential would represent a new modality for the treatment of obesity and related metabolic disorders –

- ThermoStem® is an off-the-shelf platform, well-protected by a comprehensive portfolio of issued patents that cover both the U.S. and international markets –

Read more at globenewswire.com

BIORESTORATIVE THERAPIES INC

NASDAQ:BRTX (12/15/2025, 8:09:24 PM)

After market: 1.11 0 (0%)

1.11

0 (0%)



Find more stocks in the Stock Screener

Follow ChartMill for more